Danaher Co. (NYSE:DHR) has been assigned an average recommendation of “Buy” from the sixteen research firms that are covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $147.57.
A number of equities research analysts recently weighed in on DHR shares. Stifel Nicolaus reiterated a “hold” rating and set a $150.00 price objective on shares of Danaher in a report on Thursday, November 14th. Credit Suisse Group restated an “outperform” rating and issued a $151.00 target price on shares of Danaher in a research note on Monday, October 14th. Wolfe Research set a $154.00 target price on shares of Danaher and gave the stock a “buy” rating in a research report on Friday, October 25th. Needham & Company LLC decreased their price target on shares of Danaher from $155.00 to $152.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Finally, UBS Group boosted their price target on Danaher from $158.00 to $165.00 and gave the company a “buy” rating in a report on Monday, December 2nd.
Danaher stock traded up $0.61 during mid-day trading on Friday, hitting $149.45. The company’s stock had a trading volume of 1,778,067 shares, compared to its average volume of 3,202,802. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.09 and a current ratio of 3.43. The company has a 50 day moving average of $140.94 and a 200-day moving average of $140.24. Danaher has a one year low of $94.59 and a one year high of $149.61. The stock has a market cap of $106.46 billion, a PE ratio of 33.11, a P/E/G ratio of 2.62 and a beta of 0.92.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.46%. Danaher’s payout ratio is 15.04%.
Large investors have recently bought and sold shares of the company. WealthPLAN Partners LLC grew its position in Danaher by 2.0% in the third quarter. WealthPLAN Partners LLC now owns 3,580 shares of the conglomerate’s stock worth $491,000 after acquiring an additional 70 shares during the period. River Wealth Advisors LLC lifted its stake in Danaher by 0.4% in the third quarter. River Wealth Advisors LLC now owns 16,838 shares of the conglomerate’s stock valued at $2,432,000 after buying an additional 73 shares during the last quarter. MBM Wealth Consultants LLC boosted its holdings in shares of Danaher by 2.0% in the second quarter. MBM Wealth Consultants LLC now owns 3,701 shares of the conglomerate’s stock valued at $529,000 after acquiring an additional 74 shares during the period. JGP Global Gestao de Recursos Ltda. boosted its holdings in shares of Danaher by 2.0% in the third quarter. JGP Global Gestao de Recursos Ltda. now owns 3,718 shares of the conglomerate’s stock valued at $537,000 after acquiring an additional 74 shares during the period. Finally, Copperwynd Financial LLC grew its position in shares of Danaher by 1.9% during the second quarter. Copperwynd Financial LLC now owns 4,144 shares of the conglomerate’s stock worth $592,000 after acquiring an additional 79 shares during the last quarter. Institutional investors and hedge funds own 78.16% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Article: Initial Coin Offerings entail a high degree of risk
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.